[1] 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南.肝脏,2015,20:750-767. [2] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2012年版).中华肝脏病杂志,2013,21:177-183. [3] Chalasani NP,Hayashi PH,Bonkovsky HL,et al.ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury.Am J Gastroenterol,2014,109:950-966. [4] Bjornsson ES.Epidemiology and risk factors for idiosyncratic drug-induced liver injury.Semin Liver Dis,2014,34:115-122. [5] Chang B,Li B,Huang A,et al.Changes of four common non-infectious liver diseases for the hospitalized patients in Beijing 302 hospital from 2002 to 2013.Alcohol,2016,54:61-65. [6] Sgro C,Clinard F,Ouazir K,et al.Incidence of drug-induced hepatic injuries: a French population-based study.Hepatology,2002,36:451-455. [7] Bjornsson ES,Bergmann OM,Bjornsson HK,et al.Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.Gastroenterology,2013,144:1419-1425. [8] Lee WM.Drug-induced acute liver failure.Clin Liver Dis,2013,17:575-586. [9] 刘晓燕,陈婧,王晓霞,等.3233例急性、亚急性、慢加急性肝衰竭病因特点分析.临床医学工程,2012,19:0823-0825. [10] 中华医学会消化病学分会肝胆疾病协作组.全国多中心急性药物性肝损伤住院病例调研分析.中华消化杂志,2007,27:439-442. [11] 滕光菊,张伟,孙颖,等.141例药物性肝衰竭临床特征及预后分析.传染病信息,2011,24:0286-0829. [12] 董培玲,李宏静,高冀蓉,等.药物性肝功能衰竭44例临床特征分析.中国医药导报,2017,14:0112-0115. [13] Zhang P,Ye Y,Yang X,et al.Systematic review on Chinese herbal medicine induced liver injury.Evid Based Complement Alternat Med,2016,2016:3560812. [14] Gao H,Li N,Wang JY,et al.Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.J Dig Dis,2012,13:33-39. [15] Zhu Y,Niu M,Chen J,et al.Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients.J Gastroenterol Hepatol,2016,31:1476-1482. [16] Lee WM.Drug-induced hepatotoxicity.N Engl J Med,2003,349:474-485. [17] Andrade RJ,Lucena MI,Fernandez MC,et al.Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.Gastroenterology,2005,129:512-521. [18] Chalasani N,Bonkovsky HL,Fontana R,et al.Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study.Gastroenterology,2015,148:1340-1352. [19] Pais R,Rusu E,Ratziu V.The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease.Clin Liver Dis,2014,18:165-178. [20] 王晓瑜,程能能.163例严重药物性肝损害不良反应报告分析.上海医药,2014,35: 35-38. [21] Antoine DJ,Dear JW,Lewis PS,et al.Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.Hepatology,2013,58:777-787. [22] 高志良,张晓红.肝衰竭并发症的治疗.中华肝脏病杂志,2010,18:811-813. [23] Reuben A,Koch DG,Lee WM,et al.Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.Hepatology,2010,52:2065-2076. |